BlackRock, Inc. 13D and 13G filings for Gilead Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-24 09:27 am Sale |
2025-03-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
101,739,273 8.200% |
-21,051,024 (-17.14%) |
Filing |
| 2024-01-24 2:27 pm Sale |
2023-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
122,790,297 9.900% |
-8,765,472 (-6.66%) |
Filing |
| 2023-01-31 08:55 am Purchase |
2022-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
131,555,769 10.500% |
4,623,076 (+3.64%) |
Filing |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
126,932,693 10.100% |
7,971,487 (+6.70%) |
Filing |
| 2022-02-01 5:14 pm Purchase |
2021-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
118,961,206 9.500% |
7,777,872 (+7.00%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
111,183,334 8.900% |
4,709,740 (+4.42%) |
Filing |